We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

69 hedge funds and large institutions have $370M invested in Cogent Biosciences in 2020 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

438% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 8

307% more capital invested

Capital invested by funds: $91M → $370M (+$279M)

97% more funds holding

Funds holding: 35 → 69 (+34)

89.27% more ownership

Funds ownership: 23.86% → 113.14% (+89%)

89% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 9

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

Holders
69
Holders Change
+34
Holders Change %
+97.14%
% of All Funds
1.22%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.11%
New
43
Increased
17
Reduced
9
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$18.1M
2
BI
BVF Inc
California
+$16.8M
3
LGM
Logos Global Management
California
+$13.7M
4
PA
Perceptive Advisors
New York
+$13.2M
5
GTC
Ghost Tree Capital
New York
+$12.1M

Top Sellers

Rank Fund Capital Flow
1
SB
Samsara BioCapital
California
-$9.14M
2
Millennium Management
Millennium Management
New York
-$2.82M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$1M
4
ACP
Acuta Capital Partners
California
-$959K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$757K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
26
Tekla Capital Management
Massachusetts
$6.04M +$2.88M +261,948 +95%
APM
27
Avidity Partners Management
Texas
$5.84M +$5.71M +519,645 New
NLVP
28
New Leaf Venture Partners
New York
$5.5M +$445K +40,494 +9%
PIM
29
Platinum Investment Management
Australia
$5.34M +$5.23M +475,705 New
CS
30
Candriam SCA
Luxembourg
$5.33M +$5.22M +474,730 New
ACM
31
Altium Capital Management
New York
$4.86M +$4.75M +432,563 New
Point72 Asset Management
32
Point72 Asset Management
Connecticut
$4.55M +$4.45M +405,000 New
Axa
33
Axa
France
$4.39M +$4.29M +390,659 New
SCM
34
Silverarc Capital Management
Massachusetts
$2.64M +$2.58M +235,066 New
Geode Capital Management
35
Geode Capital Management
Massachusetts
$2.38M +$2.06M +187,699 +761%
ECM
36
ExodusPoint Capital Management
New York
$1.51M +$1.48M +134,850 New
SSA
37
Schonfeld Strategic Advisors
New York
$1.38M +$1.35M +122,476 New
MCM
38
Moore Capital Management
New York
$1.27M +$1.24M +113,030 New
JP Morgan Chase
39
JP Morgan Chase
New York
$755K +$739K +67,214 New
Northern Trust
40
Northern Trust
Illinois
$601K +$511K +46,552 +672%
BCM
41
Bridgeway Capital Management
Texas
$525K -$7.86K -715 -2%
Millennium Management
42
Millennium Management
New York
$517K -$2.82M -256,370 -85%
IC
43
Ikarian Capital
Texas
$469K +$459K +41,762 New
Citigroup
44
Citigroup
New York
$452K +$442K +40,266 New
QSS
45
Quantitative Systematic Strategies
Florida
$415K +$406K +36,931 New
Renaissance Technologies
46
Renaissance Technologies
New York
$364K -$602K -54,822 -63%
HA
47
HC Advisors
Georgia
$353K +$345K +31,395 New
Two Sigma Advisers
48
Two Sigma Advisers
New York
$341K +$333K +30,347 New
MFS
49
Mirabella Financial Services
United Kingdom
$325K +$318K +28,920 New
SFI
50
Susquehanna Fundamental Investments
Pennsylvania
$287K +$96.2K +8,751 +52%
1
2
3 4

COGT Hedge Fund Activity: Q4 2020 in Review

69 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q4 2020, worth a combined $370M — up 307% from $91M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new COGT positions and 8 closed out — a net gain of 35 holders — while 17 added to existing stakes and 9 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $18.1M. The largest seller was Samsara BioCapital, cutting an estimated $9.14M.

  • 69 institutional investors held Cogent Biosciences (COGT) as of Q4 2020, up from 35 in Q3 2020.
  • Funds reported $370M of Cogent Biosciences stock for Q4 2020, up 307% quarter-over-quarter.
  • 43 funds opened new Cogent Biosciences positions in Q4 2020 and 8 closed out, a net change of +35 holders.
  • The largest Cogent Biosciences buyer in Q4 2020 was Janus Henderson Group, an estimated $18.1M added.
  • The largest Cogent Biosciences seller in Q4 2020 was Samsara BioCapital, an estimated $9.14M sold.

Based on aggregated 13F filings for Q4 2020.